Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.34 |
| ▸ | CCR3 | P51677 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12923046 | 0.82 | SLC6A2 (0.57) | CYP2D6SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL12923049 | 0.80 | MAOA (0.43) | KDM4EKMT2ACYP2D6SLC6A2SLC6A4 | |
| SCHEMBL12923048 | 0.80 | CYP2D6 (0.46) | KDM4EKMT2AOPRM1NR3C1CYP2D6 | |
| SCHEMBL982298 | 0.79 | PDE4A (0.39) | KDM4EKMT2ANR3C1CYP2D6ALDH1A1 | |
| SCHEMBL2798825 | 0.77 | PDE4A (0.38) | KDM4EKMT2ANR3C1CYP2D6ALDH1A1 | |
| SCHEMBL985219 | 0.74 | SLC6A2 (0.64) | KDM4EKMT2AOPRM1NR3C1CYP2D6 | |
| SCHEMBL985221 | 0.72 | CYP2D6 (0.45) | KDM4EKMT2ANR3C1CYP2D6SLC6A2 | |
| SCHEMBL981974 | 0.70 | CYP2D6 (0.46) | KDM4EKMT2ANR3C1CYP2D6SLC6A2 | |
| SCHEMBL980880 | 0.69 | SLC6A2 (0.61) | KDM4EKMT2AOPRM1NR3C1SLC6A2 | |
| SCHEMBL984260 | 0.69 | SLC6A2 (0.63) | KDM4EKMT2ANR3C1CYP2D6SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110021556-A1 | PYRROLIDINYL DERIVATIVES AND USES THEREOF | HOFFMAN-LA ROCHE, INC. (US) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021556-A1 | PYRROLIDINYL DERIVATIVES AND USES THEREOF | SLC6A3, MAOB, TPH2 | KDM4E 680/4885KMT2A 2106/4885OPRM1 203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.